Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

被引:8
|
作者
Sola-Morales, Oriol [1 ]
Siguroardottir, Katla [1 ]
Akehurst, Ron [2 ]
Murphy, Linda A. [2 ]
Mestre-Ferrandiz, Jorge
Cunningham, David
de Pouvourville, Gerard [3 ]
机构
[1] Fdn HiTT, Barcelona, Spain
[2] Lumanity Inc, Sheffield, England
[3] ESSEC Business Sch, Cergy Pontoise, France
关键词
data governance; real-world data; real-world evidence; BIG DATA; TASK-FORCE; HEALTH;
D O I
10.1016/j.jval.2023.02.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Real-world data (RWD) and real-world evidence (RWE) can provide extensive information on healthcare for use in health technology assessment and decision making. Nevertheless, there is a lack of consensus surrounding the appropriate data governance (DG) practices for RWD/RWE. Data sharing is also a large concern, especially considering evolving data protection regulations. Our objective is to propose recommendations for international standards of evaluating the acceptability of RWD governance practices. Methods: After reviewing the literature, we created a checklist targeting DG practices for RWD/RWE. We then carried out a 3-round Delphi panel, including European policy makers, health technology assessment experts, and hospital managers. The consensus for each statement was measured and the checklist adjusted accordingly. Results: The literature review identified the main topics regarding RWD/RWE DG practices: data privacy and security, data management and linkage, data access management, and the generation and use of RWE. Members of the Delphi panel (21 experts/25 invited) were presented a total of 24 statements related to each of the topics. Experts demonstrated a progressive level of consensus and importance ratings in all topics and to most statements. We suggest a refined checklist in which the statements rated less important or with less consensus have been removed. Conclusions: This study suggests how the DG of RWD/RWE could be qualitatively evaluated. We propose checklists that could be used by all RWD/RWE users to help ensure the quality and integrity of RWD/RWE governance and complement data protection law.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 50 条
  • [21] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea
    Lee, Hankil
    Ahn, Hyeon-Soo
    Kwon, Sol
    Kang, Hye-Young
    Han, Euna
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [22] What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
    Kc, Sarin
    Lin, Lydia Wenxin
    Bayani, Diana Beatriz Samson
    Zemlyanska, Yaroslava
    Adler, Amanda
    Ahn, Jeonghoon
    Chan, Kelvin
    Choiphel, Dechen
    Genuino-Marfori, Anne Julienne
    Kearney, Brendon
    Liu, Yuehua
    Nakamura, Ryota
    Pearce, Fiona
    Prinja, Shankar
    Pwu, Raoh-Fang
    Shafie, Arsul Akmal
    Sui, Binyan
    Suwantika, Auliya
    Tunis, Sean
    Wu, Hui-Min
    Zalcberg, John
    Zhao, Kun
    Isaranuwatchai, Wanrudee
    Teerawattananon, Yot
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2023, 12
  • [23] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [24] External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges
    Gillis Carrigan
    Brian D. Bradbury
    M. Alan Brookhart
    William B. Capra
    Victoria Chia
    Kenneth J. Rothman
    Khaled Sarsour
    Michael D. Taylor
    Jefferey S. Brown
    Current Epidemiology Reports, 2022, 9 : 326 - 337
  • [25] Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making
    Davis, Kourtney
    Yost, Emily
    Brauneis, Jacquelyne
    Krumme, Alexis
    Geldhof, Anja
    Tuck, Astrud
    Sylvester, Shirley
    Ephross, Sara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [26] External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges
    Carrigan, Gillis
    Bradbury, Brian D.
    Brookhart, M. Alan
    Capra, William B.
    Chia, Victoria
    Rothman, Kenneth J.
    Sarsour, Khaled
    Taylor, Michael D.
    Brown, Jefferey S.
    CURRENT EPIDEMIOLOGY REPORTS, 2022, 9 (04) : 326 - 337
  • [27] Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
    Alnofal, Fatemah A.
    Alrwisan, Adel A.
    Alshammari, Thamir M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1303 - 1306
  • [28] Multidimensional Evidence Generation and FDA Regulatory Decision Making Defining and Using "Real-World" Data
    Jarow, Jonathan P.
    LaVange, Lisa
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (08): : 703 - 704
  • [29] Development of audit readiness considerations of real-world data for use in regulatory decision-making
    Atzinger, Christopher B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 411 - 411
  • [30] Lessons for regulatory decision-making from real-world data trial emulation results
    Wang, Shirley
    Schneeweiss, Sebastian
    Crown, William
    Ross, Joseph
    Arlett, Peter
    Quinto, Kenneth
    Uyama, Yoshiaki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 8 - 8